John Wiley

Jan 7, 2025 | asmepublications.onlinelibrary.wiley.com | Sarah George |John Wiley

1 REFLECTING ON THE SPECTRUM OF INVOLVEMENT: HOW DO WE INVOLVE PATIENTS AS PARTNERS IN EDUCATION? Patients are expected to be actively engaged as partners in education. However, little is known about what these partnerships mean and how they can be achieved in practice. This qualitative case study explored patients', educators' and students' perceptions of patient partnerships in health care education.

Dec 6, 2024 | reporter.am | John Wiley

Sora Investors LLC trimmed its holdings in Applied Optoelectronics, Inc. (NASDAQ:AAOI – Free Report) by 44.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 250,000 shares of the semiconductor company’s stock after selling 200,000 shares during the period.

Dec 5, 2024 | slatersentinel.com | John Wiley |Bob Marten

Korn Ferry (NYSE:KFY) Releases Q3 2025 Earnings Guidance Korn Ferry (NYSE:KFY – Get Free Report) updated its third quarter 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 1.060-1.180 for the period, compared to the consensus estimate of 1.150. The company issued revenue guidance of -.

Dec 5, 2024 | markets.financialcontent.com | John Wiley

(5) On August 31, 2024, we completed the sale of CrossKnowledge. The pretax loss on sale was $51.5 million (net of tax loss of $51.5 million). In connection with the held-for-sale classification, we recognized cumulative impairment charges of $51.0 million which included $55.4 million recognized in fiscal year 2024 and a reduction of $4.4 million in the three months ended July 31, 2024.

Dec 5, 2024 | ca.investing.com | John Wiley

Stock Story - Educational publishing company John Wiley & Sons (NYSE:WLY) reported revenue ahead of Wall Street’s expectations in Q3 CY2024, but sales fell by 13.4% year on year to $426.6 million. The company expects the full year’s revenue to be around $1.67 billion, close to analysts’ estimates. Its non-GAAP profit of $0.97 per share was 38.6% above analysts’ consensus estimates. Is now the time to buy John Wiley & Sons? Find out by reading the original article on StockStory, it’s free.